michigan semaglutide gastrointestinal obstruction attorney The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know semaglutide bowel obstruction attorney in

These data provide confidence to proceed to a phase 3 trial in idiopathic intracranial hypertension and highlight the potential to utilize GLP-1 receptor agonist in other conditions characterized by raised intracranial pressure

Once in circulation, GLP-1 exerts powerful metabolic effects: it enhances glucose-dependent insulin secretion from the pancreas, suppresses excess glucagon, and signals the hypothalamic nuclei in the brain to promote satiety

About 10% of users reported indigestion while taking semaglutide, highlighting that gastrointestinal responses vary and some effects are relatively common

This gives people a new option for managing their weight under medical supervision